Pedro P. López‐Casas
- Oncology top 5%
- Molecular Biology top 10%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Immunology top 10%
- Co-authors
- Manuel HidalgoMónica MusteanuFernando López‐RíosJesús del MazoCamino MenéndezManuel MuñozEmilio González-GonzálezCarmen Guerra
- Topics
- Pancreatic and Hepatic Oncology Research (16 papers)Cancer Genomics and Diagnostics (14 papers)Cancer Cells and Metastasis (5 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Pedro P. López‐Casas
49 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 102
- Oncology 978
- Molecular Biology 702
- Cancer Research 540
- Pulmonary and Respiratory Medicine 340
- Immunology 317
Countries citing papers authored by Pedro P. López‐Casas
This map shows the geographic impact of Pedro P. López‐Casas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro P. López‐Casas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro P. López‐Casas more than expected).
Fields of papers citing papers by Pedro P. López‐Casas
This network shows the impact of papers produced by Pedro P. López‐Casas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro P. López‐Casas. The network helps show where Pedro P. López‐Casas may publish in the future.
Co-authorship network of co-authors of Pedro P. López‐Casas
This figure shows the co-authorship network connecting the top 25 collaborators of Pedro P. López‐Casas. A scholar is included among the top collaborators of Pedro P. López‐Casas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro P. López‐Casas. Pedro P. López‐Casas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 79 | |
| 2 | 74 | |
| 3 | 35 | |
| 4 | 64 | |
| 5 | 103 | |
| 6 | 23 | |
| 7 | 54 | |
| 8 | 60 | |
| 9 | 7 | |
| 10 | 6 | |
| 11 | 102 | |
| 12 | 25 | |
| 13 | 107 | |
| 14 | 21 | |
| 15 | Iatrogenic equine metabolic syndrome in thoroughbred horses | 0 |
| 16 | 24 | |
| 17 | 10 | |
| 18 | 10 | |
| 19 | 8 | |
| 20 | 3 |
About Pedro P. López‐Casas
Pedro P. López‐Casas is a scholar working on Cancer Research, Equine and Oncology, having authored 52 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (16 papers), Cancer Genomics and Diagnostics (14 papers) and Cancer Cells and Metastasis (5 papers). The work is most often cited by research in Cancer Research (540 citations), Oncology (978 citations) and Immunology (317 citations). Pedro P. López‐Casas has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Manuel Hidalgo, Mónica Musteanu, Fernando López‐Ríos, Jesús del Mazo, Camino Menéndez, Manuel Muñoz, Emilio González-González, Carmen Guerra, Carlos Plaza and Mariano Barbacid. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.